Enrolling By InvitationNCT06736769
Ketamine Effects on Learning In Eating disorders
Medication studyAges 16–26United States
Understand this study
Who could participate?
Listed age limits: 16 years to 26 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 5, 2025
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 20
- Sponsor
- Amanda Downey, MD
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 16 Years to 26 Years
- Official registry ID
- NCT06736769
- Official title
Show the full official title
"KETTLE" Trial: Ketamine Effects on Learning In Eating Disorders
Recruitment & locations
By invitationThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Amanda Downey, MD.
Does this study involve medication?
Yes. The study involves medication, including Ketamine infusion.
Who can participate?
Listed age limits: 16 years to 26 years.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
